D. Morgan, F. Ruscetti, and R. Gallo, Selective in vitro growth of T lymphocytes from normal human bone marrows, Science, vol.193, issue.4257, pp.1007-1015, 1976.
DOI : 10.1126/science.181845

T. Taniguchi, H. Matsui, and T. Fujita, Structure and expression of a cloned cDNA for human interleukin-2, Nature, vol.126, issue.5906, pp.305-315, 1983.
DOI : 10.1038/302305a0

Y. Rochman, R. Spolski, and W. Leonard, New insights into the regulation of T cells by ??c family cytokines, Nature Reviews Immunology, vol.223, issue.7, pp.480-90, 2009.
DOI : 10.1038/nri2580

T. Waldmann, C. Goldman, and L. Top, The Interleukin-2 Receptor: A Target for Immunotherapy, Annals of the New York Academy of Sciences, vol.50, issue.1 Immunomodulat, pp.603-613, 1993.
DOI : 10.1073/pnas.87.21.8291

B. Sadlack, H. Merz, and H. Schorle, Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene, Cell, vol.75, issue.2, pp.253-61, 1993.
DOI : 10.1016/0092-8674(93)80067-O

H. Suzuki, T. Kündig, and C. Furlonger, Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta, Science, vol.268, issue.5216, pp.1472-76, 1995.
DOI : 10.1126/science.7770771

D. Willerford, J. Chen, and J. Ferry, Interleukin-2 receptor ?? chain regulates the size and content of the peripheral lymphoid compartment, Immunity, vol.3, issue.4, pp.521-530
DOI : 10.1016/1074-7613(95)90180-9

S. Sakaguchi, N. Sakaguchi, and M. Asano, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor ?-chains (CD25) Breakdown of a single mechanism of selftolerance causes various autoimmune diseases, J Immunol, vol.155, pp.1151-64, 1995.

T. Malek, A. Yu, and V. Vincek, CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2R??-Deficient Mice, Immunity, vol.17, issue.2, pp.167-78, 2002.
DOI : 10.1016/S1074-7613(02)00367-9
URL : http://doi.org/10.1016/s1074-7613(02)00367-9

S. Hori, T. Nomura, and S. Sakaguchi, Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-61, 2003.
DOI : 10.1126/science.1079490

J. Fontenot, M. Gavin, and A. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nature Immunology, vol.4, issue.4, pp.330-366, 2003.
DOI : 10.1038/ni904

J. Snow, N. Abraham, and M. Ma, Loss of Tolerance and Autoimmunity Affecting Multiple Organs in STAT5A/5B-Deficient Mice, The Journal of Immunology, vol.171, issue.10, pp.5042-50, 2003.
DOI : 10.4049/jimmunol.171.10.5042

C. Baecher-allan, J. Brown, G. Freeman, and D. Hafler, CD4+CD25high Regulatory Cells in Human Peripheral Blood, The Journal of Immunology, vol.167, issue.3, pp.1245-53, 2001.
DOI : 10.4049/jimmunol.167.3.1245

H. Jonuleit, E. Schmitt, and M. Stassen, T Cells with Regulatory Properties Isolated from Peripheral Blood, The Journal of Experimental Medicine, vol.160, issue.11, pp.1285-94, 2001.
DOI : 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q

D. Moraes-vasconcelos, B. Costa-carvalho, T. Torgerson, and H. Ochs, Primary Immune Deficiency Disorders Presenting as Autoimmune Diseases: IPEX and APECED, Journal of Clinical Immunology, vol.115, issue.1, pp.11-20, 2008.
DOI : 10.1007/s10875-008-9176-5

C. Roifman, Human IL-2 Receptor ?? Chain Deficiency, Pediatric Research, vol.90, issue.1, pp.6-11, 2000.
DOI : 10.1203/00006450-200007000-00004

H. Zhang, K. Chua, and M. Guimond, Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells, Nature Medicine, vol.171, issue.11, pp.1238-1281, 2005.
DOI : 10.1016/S0140-6736(00)02293-5

M. Ahmadzadeh and S. Rosenberg, IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients, Blood, vol.107, issue.6, pp.2409-2423, 2006.
DOI : 10.1182/blood-2005-06-2399
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473973

K. Vang, J. Yang, and S. Mahmud, IL-2, -7, and -15, but Not Thymic Stromal Lymphopoeitin, Redundantly Govern CD4+Foxp3+ Regulatory T Cell Development, The Journal of Immunology, vol.181, issue.5, pp.3285-90, 2008.
DOI : 10.4049/jimmunol.181.5.3285

M. Williams, A. Tyznik, and M. Bevan, Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells, Nature, vol.8, issue.7095, pp.890-893, 2006.
DOI : 10.1038/nature04790

S. Bensinger, P. Walsh, and J. Zhang, Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells, The Journal of Immunology, vol.172, issue.9, pp.5287-96, 2004.
DOI : 10.4049/jimmunol.172.9.5287

A. Yu, I. Snowhite, and F. Vendrame, Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes, Diabetes, vol.64, issue.6, pp.2172-83, 2015.
DOI : 10.2337/db14-1322

M. Giedlin and R. Zimmerman, The use of recombinant human interleukin-2 in treating infectious diseases, Current Opinion in Biotechnology, vol.4, issue.6, pp.722-728, 1993.
DOI : 10.1016/0958-1669(93)90056-3

J. Kovacs, M. Baseler, and R. Dewar, Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection ??? A Preliminary Study, New England Journal of Medicine, vol.332, issue.9, pp.567-75, 1995.
DOI : 10.1056/NEJM199503023320904